Eve Versage

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica

P. Rolan, E. Aycardi, G. O'neill, 2015, PloS one.

Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.

P. Chanthavanich, M. Hohenboken, E. Versage, 2021, Vaccine.

Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions

M. Hohenboken, E. van Twuijver, Tino F. Schwarz, 2024, Vaccines.

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults

Sharon Frey, M. Hohenboken, E. van Twuijver, 2023, Human vaccines & immunotherapeutics.

Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults

M. Hohenboken, Daphne C Sawlwin, E. Versage, 2021, Vaccines.